Gainers

• Apimeds Pharmaceuticals (AMEX:APUS) stock moved upwards by 76.7% to $5.69 during Monday's pre-market session. The market value of their outstanding shares is at $4.8 million.
• Alector (NASDAQ:ALEC) shares rose 56.9% to $2.84. The company's market cap stands at $202.0 million.
• Vaxcyte (NASDAQ:PCVX) shares moved upwards by 54.92% to $87.5. The company's market cap stands at $8.4 billion.
• Stablecoin Development (AMEX:SDEV) shares rose 49.42% to $11.18. The market value of their outstanding shares is at $202.8 million.
• QTREX Quantum (NASDAQ:QTEX) stock rose 19.09% to $1.31. The market value of their outstanding shares is at $73.7 million.
• Jaguar Health (NASDAQ:JAGX) shares moved upwards by 15.84% to $4.24. The market value of their outstanding shares is at $1.9 million.

Losers

• Sunshine Biopharma (NASDAQ:SBFM) stock declined by 20.5% to $0.53 during Monday's pre-market session. The market value of their outstanding shares is at $2.5 million.
• Pomdoctor (NASDAQ:POM) stock fell 18.42% to $0.7. The market value of their outstanding shares is at $7.9 million.
• Healthcare Triangle (NASDAQ:HCTI) shares fell 16.14% to $0.61. The company's market cap stands at $1.4 million.
• SILO Pharma (NASDAQ:SILO) shares fell 14.92% to $1.24. The company's market cap stands at $2.5 million.
• NewGenIvf Group (NASDAQ:NIVF) stock declined by 13.42% to $0.11.
• Xenetic Biosciences (NASDAQ:XBIO) stock declined by 10.27% to $2.01. The market value of their outstanding shares is at $5.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.